There’s another life sciences building coming to the Boston area. This time, its a nine-story, 289,000-square-foot project off South Street in Somerville’s Boynton Yards project.
Developers DLJ Real Estate Capital Partners and Leggat McCall announced this month that they had started construction on the building at 101 South Street. The developers said in a release that it will be “the largest state-of-the-art lab development in Somerville’s growing life science market.”
They also touted its proximity to Somerville’s Union Square as well as Cambridge’s Inman and Kendall squares, the latter one the top biotech-tech hub in the region. The South Street life sciences building is also going to be near the future Union Square stop on the extended Green Line.
And 101 South will be part of the nearly 3.5-acre, more than 1 million-square-foot Boynton Yards project, which is sure to include other commercial space as well as performing arts space and approximately 425 residences. The ongoing project will fill in what’s now parking lots, scrapyards, and industrial properties.
The 101 South piece is the latest life sciences building planned or underway in the Boston region. Others are slated for Waltham, elsewhere in Somerville, and near the Broadway T stop in South Boston. The additions come as biotech and tech in general come to occupy more and more commercial space in the region—and to drive more of its housing market.
The Boynton Yards building is expected to be finished and ready for move-ins by summer 2021. Stay tuned.